Dialysis Tubing Sales

Dialysis Tubing Sales Market Outlook

The global dialysis tubing market has been valued at approximately USD 1.5 billion in 2025 and is projected to grow at a compound annual growth rate (CAGR) of about 6.2% from 2025 to 2035. This growth is largely driven by the increasing prevalence of chronic kidney diseases (CKD) worldwide, which necessitates reliance on dialysis as a treatment option. Furthermore, factors such as rising healthcare expenditures, advancements in dialysis technologies, and an aging population are also contributing to market expansion. The growing awareness about kidney health and the importance of dialysis in life-supporting treatments have prompted both patient and provider engagement, resulting in a favorable market scenario. Additionally, the rise in home-based dialysis treatment options is further fueling the demand for dialysis tubing, as patients seek more convenient and manageable solutions for their healthcare needs.

Growth Factor of the Market

The growth of the dialysis tubing market is propelled by several interrelated factors that collectively enhance its attractiveness to stakeholders. Firstly, the increasing incidence of kidney-related disorders, coupled with the escalating number of patients undergoing dialysis treatments, has created a significant demand for high-quality dialysis tubing. Secondly, innovations in dialysis technologies, such as improvements in biocompatibility and fluid dynamics, have prompted manufacturers to develop sophisticated tubing that meets the evolving requirements of healthcare providers and patients alike. Furthermore, the shift towards home dialysis solutions represents another critical growth factor, as patients seek greater autonomy and flexibility in managing their treatments. Thirdly, government initiatives aimed at promoting renal health and funding dialysis-related treatments are also boosting market activity. Finally, the increasing investment in healthcare infrastructure, particularly in developing regions, is expected to further catalyze growth in the dialysis tubing market.

Key Highlights of the Market

• The dialysis tubing market is projected to reach USD 2.8 billion by 2035.
• North America currently holds the largest market share, accounting for approximately 45% of global revenue.
• Cellulose-based dialysis tubing is anticipated to witness significant growth due to its widespread use in both hemodialysis and peritoneal dialysis applications.
• Homecare settings are emerging as a preferred distribution channel, driven by the growing trend of home-based healthcare solutions.
• The Asia Pacific region is expected to exhibit the highest CAGR during the forecast period, fueled by rising healthcare investments and increasing CKD prevalence.

By Product Type

Cellulose-based Dialysis Tubing:

Cellulose-based dialysis tubing has been a predominant product type in the market, owing to its biocompatibility and effective solute transport properties. This type of tubing is primarily utilized in hemodialysis and peritoneal dialysis applications, providing reliable performance at a competitive cost. Its low production cost, coupled with ease of manufacturing, has made cellulose-based tubing a preferred choice among healthcare providers. Furthermore, the tubing's compatibility with various dialysis machines adds to its appeal, ensuring that it meets the requirements of diverse patient populations. As the demand for dialysis treatments continues to grow, cellulose-based dialysis tubing is expected to maintain its significant market share and be a focal point for innovation and enhancement.

Synthetic Dialysis Tubing:

Synthetic dialysis tubing is gaining traction in the market due to its enhanced performance characteristics compared to traditional cellulose-based options. Composed of advanced materials such as polysulfone and polyethersulfone, synthetic tubing offers improved biocompatibility, higher permeability, and superior filtration efficiency. These features lead to better patient outcomes and overall satisfaction, driving the adoption of synthetic dialysis tubing in clinical settings. Additionally, as healthcare professionals increasingly prioritize patient care quality, synthetic options are expected to see a rise in demand, particularly in facilities equipped with advanced dialysis technologies. The market for synthetic dialysis tubing is anticipated to grow steadily, influenced by ongoing research and development efforts aimed at optimizing dialysis processes.

Hollow Fiber Dialysis Tubing:

Hollow fiber dialysis tubing represents an innovative approach to dialysis, featuring a unique structure that maximizes surface area for solute exchange while minimizing resistance. This technology allows for efficient blood filtration, making it highly effective for both hemodialysis and peritoneal dialysis applications. The hollow fiber design enhances mass transfer and provides patients with quicker treatment sessions, which is a significant advantage for healthcare providers looking to optimize patient throughput. Moreover, as technological advancements continue to improve the efficiency of hollow fiber membranes, this product type is expected to gain market share. The growing preference for advanced technologies in renal care is likely to drive demand for hollow fiber dialysis tubing in the coming years.

Flat Sheet Dialysis Tubing:

Flat sheet dialysis tubing is characterized by its flat, smooth structure, which is often utilized in various dialysis applications due to its versatility and adaptability. This type of tubing is commonly used in hemodialysis machines and offers reliable performance for both clinical and home-based dialysis treatments. Flat sheet designs enable easier customization for specific patient requirements and allow healthcare providers to optimize treatment protocols. Despite not being as widely adopted as hollow fiber or synthetic tubing, the flat sheet variety continues to hold a place in the market, particularly among facilities that require flexibility in their dialysis systems. The demand for flat sheet dialysis tubing is expected to remain consistent, driven by ongoing advancements in material science and production techniques.

Coil Tube Dialysis Tubing:

Coil tube dialysis tubing is an emerging product type that offers unique advantages in specific dialysis applications. This design features a coiled structure that enhances flow dynamics and reduces the likelihood of clogging during treatment. Coil tubing is particularly useful in scenarios where fluid flow management is critical, such as in certain hemodialysis configurations. The ability to customize coil dimensions allows for tailored solutions that cater to individual patient needs, providing greater flexibility for healthcare providers. As the industry continues to explore innovative designs to improve patient care, coil tube dialysis tubing is likely to gain attention, particularly in specialized treatment centers and advanced dialysis facilities.

By Application

Hemodialysis:

Hemodialysis is one of the primary applications driving the dialysis tubing market, as it is a critical treatment option for patients with end-stage renal disease. This process involves filtering blood through a dialysis machine to remove waste products, excess fluids, and toxins. The demand for high-performance dialysis tubing in hemodialysis settings is imperative to ensure efficient solute transport and optimal patient outcomes. As the global prevalence of chronic kidney diseases rises, the need for effective hemodialysis solutions will continue to drive market growth. Additionally, advancements in technology aim to enhance the efficiency and safety of hemodialysis treatments, further increasing the demand for specialized dialysis tubing tailored for this application.

Peritoneal Dialysis:

Peritoneal dialysis is another vital application within the dialysis tubing market, where the patient's peritoneal cavity is used as a natural filter to remove waste and excess fluid. The growth of peritoneal dialysis is largely attributed to its favorable outcomes, flexibility, and suitability for home-based treatment. The increasing preference for self-administered dialysis options has prompted healthcare professionals to seek high-quality dialysis tubing that ensures effective fluid exchange and minimizes the risk of infection. As patients increasingly opt for peritoneal dialysis, the demand for corresponding dialysis tubing is expected to rise, with manufacturers focusing on creating products that enhance performance and patient safety.

Other Dialysis Treatments:

Other dialysis treatments encompass a range of specialized procedures that may require unique dialysis tubing configurations. These treatments often involve innovative techniques or adaptations of standard dialysis methods to cater to specific patient needs. The growth of this segment is indicative of the evolving landscape of renal care, as healthcare providers explore alternative approaches to support patients in managing their kidney health. The demand for customized dialysis tubing products tailored for these specialized applications is expected to increase, particularly as research and development efforts continue to identify novel treatment methodologies. As awareness and understanding of various dialysis options expand, the market for other dialysis treatments will likely experience notable growth.

By Distribution Channel

Hospitals & Clinics:

Hospitals and clinics represent the primary distribution channel for dialysis tubing, accounting for a significant share of the market. These institutions are equipped with advanced dialysis technology and provide essential care to a large population of patients undergoing renal treatments. The demand for high-quality dialysis tubing in hospital settings is driven by the imperative to ensure patient safety and effective treatment outcomes. Healthcare providers in these facilities prioritize reliability and performance when selecting dialysis tubing, which has led to a focus on high-quality materials and innovative designs. As the global burden of chronic kidney disease continues to rise, the hospitals and clinics segment is likely to maintain its dominance in the dialysis tubing market, supported by ongoing investments in healthcare infrastructure.

Ambulatory Surgical Centers:

Ambulatory surgical centers (ASCs) are becoming an increasingly important distribution channel for dialysis tubing, as they offer a convenient alternative for patients requiring outpatient procedures. The growth of ASCs is driven by the shift towards outpatient care and the focus on cost-effective treatment options. In these settings, dialysis tubing must meet stringent quality standards to ensure patient safety and effective treatment delivery. The demand for dialysis tubing in ASCs is influenced by the need for efficiency and timely access to care, as patients seek to minimize hospital stays. As the trend toward outpatient treatment continues, ASCs are expected to play a larger role in the dialysis tubing market, leading to increased demand for specialized products designed for these facilities.

Homecare Settings:

Homecare settings represent a rapidly growing distribution channel for dialysis tubing, largely driven by the increasing preference for home-based dialysis solutions. Patients opting for home dialysis benefit from greater autonomy, convenience, and comfort, leading to improved quality of life. This shift has prompted manufacturers to develop dialysis tubing specifically designed for homecare applications, focusing on ease of use and safety. The demand for home dialysis is further fueled by the rising number of patients choosing peritoneal dialysis, which is well-suited for home treatment. As healthcare providers recognize the importance of patient-centered care, the homecare settings segment is expected to experience significant growth, contributing to the overall expansion of the dialysis tubing market.

By Material Type

Cellulose:

Cellulose is a traditional material used in the production of dialysis tubing, valued for its biocompatibility and affordability. This material has been a staple in the dialysis industry for many years, primarily utilized in hemodialysis and peritoneal dialysis applications. The cellulose-based tubing provides adequate solute transport properties, making it a reliable option for healthcare providers. However, as innovations in dialysis technology continue to evolve, there is a growing demand for tubing materials with enhanced performance characteristics. While cellulose remains a significant player in the market, manufacturers are exploring advanced materials to meet the changing needs of patients and healthcare professionals.

Polysulfone:

Polysulfone has emerged as a key material type in the dialysis tubing market, recognized for its excellent biocompatibility and filtration efficacy. This synthetic polymer offers superior performance compared to traditional cellulose options, leading to higher patient satisfaction and improved outcomes. Polysulfone-based dialysis tubing is commonly used in both hemodialysis and peritoneal dialysis applications, where efficient solute exchange is critical. As the healthcare industry increasingly prioritizes patient care quality, the demand for polysulfone dialectic tubing is expected to rise. Manufacturers are also focusing on optimizing polysulfone tubing designs to further enhance performance and address specific patient needs.

Polyethersulfone:

Polyethersulfone (PES) is gaining popularity in the dialysis tubing market due to its remarkable mechanical strength and thermal stability. This advanced material offers excellent filtration properties, making it suitable for a wide range of dialysis applications. PES-based tubing is particularly valued for its ability to provide consistent performance even under varying operational conditions. As the trend towards advanced dialysis technologies continues, the demand for polyethersulfone-based products is expected to grow. Manufacturers are increasingly adopting PES in their dialysis tubing designs, focusing on creating high-performance solutions that meet the evolving requirements of healthcare providers and patients alike.

Polyvinylidene Fluoride:

Polyvinylidene fluoride (PVDF) is an emerging material type in the dialysis tubing market, known for its chemical resistance and mechanical stability. PVDF-based dialysis tubing is becoming increasingly popular among healthcare providers, particularly in applications where durability and reliability are crucial. This material's resistance to extreme temperatures and harsh chemicals makes it suitable for a variety of dialysis processes. As healthcare practitioners recognize the importance of using high-quality materials in dialysis treatments, the demand for PVDF tubing is expected to grow steadily. Manufacturers are exploring the potential of PVDF in their product offerings, focusing on innovations that enhance performance and patient outcomes.

By Region

The dialysis tubing market is geographically diverse, with key regions exhibiting varying growth patterns and dynamics. North America currently dominates the market, accounting for approximately 45% of global revenue in the dialysis tubing sector. The region's growth is attributed to its well-established healthcare infrastructure, advanced medical technologies, and a high prevalence of chronic kidney diseases. With an increasing number of patients seeking dialysis treatments, North America is expected to maintain its leading position throughout the forecast period. The market in this region is projected to grow at a CAGR of around 5.8%, driven by ongoing investments in healthcare innovations and the rising demand for high-quality dialysis products.

In contrast, the Asia Pacific region is anticipated to witness the highest growth rate over the forecast period, with a CAGR of approximately 7.5%. This growth can be attributed to the increasing prevalence of kidney disorders, a growing aging population, and rising healthcare expenditures. Developing countries within the region, such as India and China, are investing heavily in expanding their healthcare infrastructure and improving access to dialysis services. The growing awareness of renal health and the importance of dialysis treatments are also driving market expansion in the Asia Pacific region. As a result, the dialysis tubing market in this area is expected to experience significant growth, contributing to the overall global market dynamics.

Opportunities

As the dialysis tubing market evolves, numerous opportunities are emerging for manufacturers and healthcare providers alike. One significant opportunity lies in the increasing demand for home dialysis solutions. With a growing number of patients opting for home-based treatments, manufacturers can focus on developing user-friendly and efficient dialysis tubing tailored for at-home use. This trend not only benefits patients by providing convenience and flexibility but also creates a lucrative market segment for industry players. By investing in research and development, companies can innovate and enhance their product offerings, creating specialized tubing that meets the unique needs of home dialysis patients.

Another promising opportunity in the dialysis tubing market is the potential for technological advancements. With ongoing research aimed at improving dialysis processes and patient outcomes, there is considerable scope for innovation in product design and materials. Companies that prioritize the development of high-performance dialysis tubing with enhanced biocompatibility, reduced risk of infection, and optimized fluid dynamics will be well-positioned to capture a larger market share. Additionally, emerging markets in developing regions present significant growth opportunities as healthcare infrastructure continues to improve and more patients gain access to life-saving dialysis treatments.

Threats

The dialysis tubing market faces several potential threats that could impact growth and profitability. One of the most significant threats is the rising competition among manufacturers, leading to price wars and reduced profit margins. As more companies enter the dialysis tubing market, there is an increased risk of oversaturation, making it challenging for smaller players to compete. Furthermore, manufacturers must continually invest in research and development to differentiate their products and maintain a competitive edge, which can strain resources. Additionally, regulatory challenges and the need for compliance with stringent quality standards can pose significant hurdles for manufacturers, potentially causing delays in product launches and increased operational costs.

Another critical restrainer in the dialysis tubing market is the availability of alternative treatments for kidney diseases, such as kidney transplants. As advancements in transplant technology continue to improve, more patients are opting for transplants rather than relying on dialysis treatments. This shift may result in a decrease in demand for dialysis tubing and related products over time. Moreover, the overall healthcare landscape is dynamic, with changing patient preferences and treatment paradigms that could impact the reliance on dialysis therapies. Manufacturers must remain vigilant and adaptable to these changes to sustain their market presence and ensure continued growth.

Competitor Outlook

• Baxter International Inc.
• Fresenius Medical Care AG & Co. KGaA
• Medtronic plc
• Asahi Kasei Medical Co., Ltd.
• Nipro Corporation
• Terumo Corporation
• Dialysis Clinic, Inc.
• Gambro (part of Baxter)
• Kawasumi Laboratories Inc.
• Hyphen Medical
• JMS Co., Ltd.
• Roche Diagnostics
• B. Braun Melsungen AG
• CareDx, Inc.
• Bellco S.R.L.

The competitive landscape of the dialysis tubing market is characterized by a multitude of players striving to capture market share through innovation and strategic initiatives. The presence of established companies such as Baxter International and Fresenius Medical Care highlights the significant role that experience and brand reputation play in this industry. These companies leverage their extensive resources to invest in research and development, allowing them to develop cutting-edge dialysis tubing solutions that address the growing needs of patients and healthcare providers. Additionally, partnerships and collaborations between manufacturers, healthcare institutions, and research organizations are becoming increasingly common, facilitating the exchange of knowledge and technological advancements that can enhance product offerings.

Emerging companies are also making their mark in the dialysis tubing market by focusing on niche segments and offering specialized products. These players often differentiate themselves through innovative designs, enhanced material properties, and a strong emphasis on patient outcomes. The market is witnessing a trend towards customization, with companies offering tailored solutions that cater to the unique needs of different dialysis applications. Furthermore, the rising emphasis on sustainability and eco-friendly products is influencing the competitive landscape, with manufacturers exploring the use of biodegradable materials and environmentally responsible practices in their production processes. As customer preferences evolve, companies that align with these trends will likely gain a competitive advantage.

Key companies in the dialysis tubing market, such as Medtronic and Nipro Corporation, are also focusing on expanding their geographic reach and product portfolios. By entering new markets and strengthening distribution networks, these companies aim to capitalize on the growing demand for dialysis treatments in emerging economies. Additionally, investing in innovative technologies, such as smart dialysis systems and home dialysis solutions, is becoming a priority for major players as they seek to enhance treatment efficiency and patient satisfaction. As the dialysis tubing market continues to evolve, the competitive landscape will remain dynamic, shaped by the interplay of established and emerging players striving to meet the needs of the global renal care community.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 CareDx, Inc.
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Bellco S.R.L.
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 JMS Co., Ltd.
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Medtronic plc
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Hyphen Medical
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Nipro Corporation
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Roche Diagnostics
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Terumo Corporation
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 B. Braun Melsungen AG
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Dialysis Clinic, Inc.
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Gambro (part of Baxter)
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Baxter International Inc.
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Kawasumi Laboratories Inc.
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Asahi Kasei Medical Co., Ltd.
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Fresenius Medical Care AG & Co. KGaA
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Dialysis Tubing Sales Market, By Application
    • 6.1.1 Hemodialysis
    • 6.1.2 Peritoneal Dialysis
    • 6.1.3 Other Dialysis Treatments
  • 6.2 Dialysis Tubing Sales Market, By Product Type
    • 6.2.1 Cellulose-based Dialysis Tubing
    • 6.2.2 Synthetic Dialysis Tubing
    • 6.2.3 Hollow Fiber Dialysis Tubing
    • 6.2.4 Flat Sheet Dialysis Tubing
    • 6.2.5 Coil Tube Dialysis Tubing
  • 6.3 Dialysis Tubing Sales Market, By Material Type
    • 6.3.1 Cellulose
    • 6.3.2 Polysulfone
    • 6.3.3 Polyethersulfone
    • 6.3.4 Polyvinylidene Fluoride
  • 6.4 Dialysis Tubing Sales Market, By Distribution Channel
    • 6.4.1 Hospitals & Clinics
    • 6.4.2 Ambulatory Surgical Centers
    • 6.4.3 Homecare Settings

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Dialysis Tubing Sales Market by Region
  • 10.6 Middle East & Africa - Market Analysis
    • 10.6.1 By Country
      • 10.6.1.1 Middle East
      • 10.6.1.2 Africa

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Dialysis Tubing Sales market is categorized based on

By Product Type

• Cellulose-based Dialysis Tubing
• Synthetic Dialysis Tubing
• Hollow Fiber Dialysis Tubing
• Flat Sheet Dialysis Tubing
• Coil Tube Dialysis Tubing

By Application

• Hemodialysis
• Peritoneal Dialysis
• Other Dialysis Treatments

By Distribution Channel

• Hospitals & Clinics
• Ambulatory Surgical Centers
• Homecare Settings

By Material Type

• Cellulose
• Polysulfone
• Polyethersulfone
• Polyvinylidene Fluoride

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Baxter International Inc.
• Fresenius Medical Care AG & Co. KGaA
• Medtronic plc
• Asahi Kasei Medical Co., Ltd.
• Nipro Corporation
• Terumo Corporation
• Dialysis Clinic, Inc.
• Gambro (part of Baxter)
• Kawasumi Laboratories Inc.
• Hyphen Medical
• JMS Co., Ltd.
• Roche Diagnostics
• B. Braun Melsungen AG
• CareDx, Inc.
• Bellco S.R.L.